萝莉社

(904) 244-0411 Education Research Community

Treats Adults

Kethandapatti Balaji, MBBS (MD), FRCS, MRCS, LRCP

Urologist

4.8 /5 410 ratings

(904) 383-1016

Request appointment online

Provider profile Menu

Provider profile Menu

Research at a glance

Research activity

44 publications

396 citations

Why is this important?

Active clinical trials

A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC who are BCG Na茂ve/Received Incomplete BCG Treatment

Investigator: Kethandapatti Balaji
Status: Accepting Candidates
Ages: 18 Years - 100 Years
Sexes: All

BCG in combination with durvalumab in adult BCG-naive, high-risk NMIBC participants

Investigator: Kethandapatti Balaji
Status: Accepting Candidates
Ages: 18 Years - 99 Years
Sexes: All

A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

Investigator: Kethandapatti Balaji
Status: Accepting Candidates
Ages: 18 Years - 100 Years
Sexes: All

My publications

44 publications

2019

Protein kinase D1 induces G1-phase cell-cycle arrest independent of Checkpoint kinases by phosphorylating Cell Division Cycle Phosphatase 25.

The Prostate

鈥�

2013

Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer.

PloS one

鈥�

2007

Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens.

Urology

2007

Protein kinase D1: a protein of emerging translational interest.

Frontiers in bioscience : a journal and virtual library